<DOC>
	<DOCNO>NCT00386763</DOCNO>
	<brief_summary>This study evaluate safety efficacy artemether-lumefantrine uncomplicated malaria cause P. falciparum child 5-35 kg bodyweight .</brief_summary>
	<brief_title>Efficacy Safety Pediatric Formulation Artemether- Lumefantrine Children With Uncomplicated P. Falciparum Malaria .</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>male female infant child ≤12 year age body weight ≥5 kg &lt; 35 kg , confirm diagnosis uncomplicated malaria cause P. falciparum parasite complicate malaria persistent vomit malaria due parasite P. falciparum antimalarial treatment receive past 2 week know chronic disease e.g . positive HIV status , severe cardiac , renal , hepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Marsh fever</keyword>
	<keyword>Plasmodium infection</keyword>
	<keyword>Remittent fever</keyword>
	<keyword>Paludism</keyword>
	<keyword>Artemether</keyword>
	<keyword>Artemisinins</keyword>
	<keyword>Malaria</keyword>
	<keyword>Benflumetol</keyword>
	<keyword>Lumefantrine</keyword>
</DOC>